➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
Colorcon
Mallinckrodt
Express Scripts
Medtronic

Last Updated: August 5, 2020

DrugPatentWatch Database Preview

COSYNTROPIN - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for cosyntropin and what is the scope of freedom to operate?

Cosyntropin is the generic ingredient in two branded drugs marketed by Amphastar Pharms Inc, Mylan Institutional, Sandoz, and Sandoz Inc, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for cosyntropin. Five suppliers are listed for this compound.

Summary for COSYNTROPIN
Recent Clinical Trials for COSYNTROPIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Chongqing Medical UniversityN/A
University of VirginiaN/A
Hill Dermaceuticals, Inc.Phase 1/Phase 2

See all COSYNTROPIN clinical trials

Pharmacology for COSYNTROPIN
Medical Subject Heading (MeSH) Categories for COSYNTROPIN

US Patents and Regulatory Information for COSYNTROPIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Institutional COSYNTROPIN cosyntropin INJECTABLE;INJECTION 090574-001 Dec 17, 2009 AP RX No No   Start Trial   Start Trial   Start Trial
Amphastar Pharms Inc CORTROSYN cosyntropin INJECTABLE;INJECTION 016750-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
Sandoz COSYNTROPIN cosyntropin INJECTABLE;INJECTION 202147-001 Jun 29, 2012 AP RX No No   Start Trial   Start Trial   Start Trial
Sandoz Inc COSYNTROPIN cosyntropin SOLUTION;INTRAVENOUS 022028-001 Feb 21, 2008 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
McKesson
Express Scripts
McKinsey
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.